Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C virus testing in primary biliary cirrhosis.

E Bertolini1, P M Battezzati, P Zermiani

  • 1First Department of Medicine, School of Medicine S. Paolo, University of Milan, Italy.

Journal of Hepatology
|May 1, 1992
PubMed
Summary

Hepatitis C virus (HCV) antibody positivity was found in 12% of primary biliary cirrhosis patients. This HCV status did not significantly impact patient survival or disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of acute lymphopenia after radiotherapy for prostate cancer including pelvic node irradiation: results of a real-world prospective multi-centric study.

ESMO real world data and digital oncology·2026
Same author

Results from the T2K Experiment on Neutrino Mixing Including a New Far Detector μ-like Sample.

Physical review letters·2026
Same author

First Differential Measurement of the Single π^{+} Production Cross Section in Neutrino Neutral-Current Scattering.

Physical review letters·2025
Same author

First Measurement of the Electron-Neutrino Charged-Current Pion Production Cross Section on Carbon with the T2K Near Detector.

Physical review letters·2025
Same author

First Joint Oscillation Analysis of Super-Kamiokande Atmospheric and T2K Accelerator Neutrino Data.

Physical review letters·2025
Same author

Chronic <i>E. Coli</i> Drug-Resistant Cystitis Treated with a Sequence of Modulated Extremely Low-Frequency Electromagnetic Fields: A Randomized Study of 148 Cases.

Journal of clinical medicine·2024

Area of Science:

  • Hepatology
  • Immunology
  • Virology

Background:

  • Primary biliary cirrhosis (PBC) is a chronic liver disease with autoimmune features.
  • Hepatitis C virus (HCV) infection is a potential co-factor in liver disease progression.

Purpose of the Study:

  • To investigate the prevalence of anti-HCV antibodies in patients with PBC.
  • To determine if anti-HCV positivity affects the clinical course and life expectancy of PBC patients.

Main Methods:

  • Retrospective analysis of 160 PBC patients diagnosed between 1980-1989.
  • Testing for anti-HCV antibodies using C-100 ELISA and second-generation ELISA.
  • Confirmation of antibody reactivity using C-100 RIBA and 4-RIBA.
  • HCV RNA detection via polymerase chain reaction (PCR).

Related Experiment Videos

  • Survival analysis to compare life expectancy between anti-HCV positive and negative groups.

    • Main Results:

    • 12% of PBC patients were initially positive for anti-HCV (C-100 ELISA).
    • Anti-HCV positivity remained stable over a median follow-up of 32 months, with increased detection by second-generation ELISA.
    • HCV RNA was not detected in any tested samples, even those reactive by RIBA.
    • No significant difference in life expectancy was observed between anti-HCV positive and negative PBC patients.

    Conclusions:

    • Anti-HCV positivity is present in a subset of PBC patients.
    • HCV infection does not appear to influence the clinical presentation or prognosis of primary biliary cirrhosis.
    • Further research may be needed to clarify the role of HCV in PBC pathogenesis.